Osteoporosis treatment involves several therapeutic tools, including long-term drug therapy. Subjects with chronic disorders are more likely to be non-adherent and/or non-persistent to treatment than those with other diseases. Adherence is the extent to which patients take medication as prescribed by their physicians, whereas persistence is the time from treatment initiation to discontinuation. Lack of persistence is common among subjects using oral anti-osteoporotic drugs, and leads to increased risk of fragility fracture.
|Titolo:||Determinants of Non-Persistence to Antiosteoporotic Drugs by Using Administrative Database|
|Data di pubblicazione:||2014|
|Appare nelle tipologie:||1.5 Abstract in rivista|